Antibody Drug Discovery and the AlivaMab Mouse

Larry Green, PhD Founder and CEO of Ablexis, LLC will present on the AlivaMab Mouse Platform, an innovative, next-generation transgenic mouse platform developed by leaders in genetic engineering and antibody drug discovery and development.

This platform is enabling the efficient discovery and development of the next generation of human therapeutic antibodies to treat human diseases and is now available to the Tri-I community. 

Thursday, April 13 at 1:30pm to 2:30pm

Belfer Research Building, BB204 - A/B
413 East 69th St., New York, NY 10021

Event Type

Lecture/Seminar

Departments

Tri-Institutional Therapeutics Discovery Institute, Meyer Cancer Center

Mission

Research

Subscribe
Google Calendar iCal Outlook

Recent Activity